Chicagoland Women’s Health

Chicagoland Women's Health in Chicago, IL provides hormone replacement therapy and peptide-based wellness programs under the medical direction of Dr. Marc Adajar, M.D., a board-certified physician specializing in women's health and metabolic optimization. The clinic focuses on evidence-based interventions for hormonal imbalances, age-related decline, and metabolic concerns affecting women throughout different life stages. Dr. Adajar's practice integrates bioidentical hormone therapy with targeted peptide protocols to address the interconnected systems that govern energy production, body composition, and overall vitality in female patients.

The clinic's peptide therapy menu includes growth hormone secretagogues specifically selected for their synergistic effects on metabolism and recovery. CJC-1295 combined with Ipamorelin forms the foundation of protocols designed to support natural growth hormone production, which typically declines after age 30. This peptide combination is utilized in weight loss management programs where patients seek to preserve lean muscle mass while reducing adipose tissue. Ipamorelin as a standalone therapy provides a shorter-acting option for patients requiring more flexible dosing schedules or those new to peptide interventions. Sermorelin, a growth hormone-releasing hormone analog, is prescribed for patients experiencing disrupted sleep architecture, diminished exercise recovery, or early signs of somatopause. These peptides are integrated into individualized treatment plans that account for each patient's hormonal profile, metabolic markers, and specific health objectives.

Dr. Adajar's approach to women's health extends beyond symptom management to address underlying hormonal and metabolic dysfunction. His board certification provides the clinical foundation for safe prescribing and monitoring of both hormone replacement protocols and peptide therapies. The clinic's weight loss management programs combine peptide therapy with nutritional guidance and metabolic assessment, recognizing that sustainable body composition changes require addressing hormonal balance, insulin sensitivity, and growth hormone status. Patients working with Dr. Adajar receive hormone panels that inform peptide selection and dosing, ensuring treatments align with individual physiology rather than following one-size-fits-all protocols.

Chicagoland Women's Health operates exclusively through in-person consultations at its Chicago location, allowing Dr. Adajar to conduct physical examinations, review laboratory results face-to-face, and establish the therapeutic relationship necessary for ongoing hormone and peptide management. Initial appointments include comprehensive health history review, discussion of symptoms related to hormonal changes, and education about how peptide therapy functions within the broader context of hormone optimization. Patients report improvements in sleep quality, sustained energy throughout the day, and enhanced recovery from physical training—outcomes consistent with optimized growth hormone signaling and balanced sex hormones. Follow-up visits allow for protocol adjustments based on patient response and repeat laboratory testing.

The clinic's location in Chicago provides access to women throughout the metropolitan area seeking alternatives to conventional approaches that may overlook the role of peptides and bioidentical hormones in metabolic health. Dr. Adajar's focus on the female patient population means treatment protocols account for the unique considerations of menstrual cycle impacts, perimenopause, menopause, and postmenopausal health. The integration of peptide therapy with hormone replacement creates comprehensive programs that address multiple aspects of aging and metabolic decline simultaneously, rather than treating each concern in isolation.